← back to search

Shari Damast

Yale Cancer Center · US
Area of research
Obstetrics and Gynecology · Reproductive Medicine
Research interest
Research interests include Endometrial and Cervical Cancer Treatments, Ovarian cancer diagnosis and treatment, Cervical Cancer and HPV Research, and Gynecological conditions and treatments.
h-index
24
citations
4,848
works
122
NIH funding
—
primary concept
Medicine
email
shari.damast@yale.edu

Recent publications

NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2025
Journal of the National Comprehensive Cancer Network 2025cited by 36position: middledoi
NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2025.
2025cited by 13position: selecteddoi
Cervical Cancer, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology
Journal of the National Comprehensive Cancer Network 2025cited by 7position: middledoi
The Prognostic Impact of MLH1 Promoter Hypermethylation in Stage I-II Endometrial Cancer Treated With Adjuvant Radiation Therapy: A Multi-Institutional Retrospective Study.
2025cited by 3position: selecteddoi
Cervical Cancer, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology.
2025cited by 0position: selecteddoi
Vulvar Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network 2024cited by 78position: middledoi
Vulvar Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.
2024cited by 51position: selecteddoi
Prognostic Effect of Mismatch Repair Status in Early-Stage Endometrial Cancer Treated With Adjuvant Radiation: A Multi-institutional Analysis.
2024cited by 3position: selecteddoi
Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network 2023cited by 537position: middledoi
NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024
Journal of the National Comprehensive Cancer Network 2023cited by 340position: middledoi
NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024.
2023cited by 276position: selecteddoi
NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021
Journal of the National Comprehensive Cancer Network 2021cited by 172position: middledoi
A phase 2 evaluation of pembrolizumab for recurrent Lynch‐like versus sporadic endometrial cancers with microsatellite instability
Cancer 2021cited by 76position: middledoi
A phase II evaluation of pembrolizumab in recurrent microsatellite instability-high (MSI-H) endometrial cancer patients with Lynch-like versus MLH-1 methylated characteristics (NCT02899793)
Annals of Oncology 2021cited by 50position: middledoi
NCCN Guidelines Insights: Cervical Cancer, Version 1.2020
Journal of the National Comprehensive Cancer Network 2020cited by 360position: middledoi
Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network 2019cited by 1,064position: middledoi
Gestational Trophoblastic Neoplasia, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network 2019cited by 136position: middledoi
Literature Review of Vaginal Stenosis and Dilator Use in Radiation Oncology
Practical Radiation Oncology 2019cited by 90position: firstdoi
Sexual Functioning Among Endometrial Cancer Patients Treated With Adjuvant High-Dose-Rate Intra-Vaginal Radiation Therapy
International Journal of Radiation Oncology*Biology*Physics 2012cited by 52position: firstdoi
—
— —cited by 0position: selecteddoi
—
— —cited by 0position: selecteddoi
—
— —cited by 0position: selecteddoi
—
— —cited by 0position: selecteddoi
—
— —cited by 0position: selecteddoi
—
— —cited by 0position: selecteddoi
—
— —cited by 0position: selecteddoi
—
— —cited by 0position: selecteddoi
—
— —cited by 0position: selecteddoi
—
— —cited by 0position: selecteddoi
—
— —cited by 0position: selecteddoi

Grants

No grants ingested yet.

Frequent collaborators

Junzo P. Chino · Purdue University Institute for Cancer Research5 papers (2023–2025)Brooke E. Howitt · Women's Hospital, School of Medicine, Zhejiang University3 papers (2023–2025)Lisa M. Landrum · Indiana University Melvin and Bren Simon Comprehensive Cancer Center2 papers (2025–2025)Stephanie Gaillard · Sidney Kimmel Cancer Center2 papers (2023–2024)Larissa Nekhlyudov · Harvard University2 papers (2023–2024)Jeanne Carter · Memorial Sloan Kettering Cancer Center2 papers (2012–2019)Ethan Basch · UNC Lineberger Comprehensive Cancer Center1 papers (2012–2012)Richard R. Barakat · Northwell Health1 papers (2012–2012)Sujata Patil · Cerner (United States)1 papers (2012–2012)Yasmin Hasan · University of Illinois Chicago1 papers (2019–2019)Rebecca C. Arend · University of South Carolina1 papers (2023–2023)Elizabeth L. Jewell · University College Dublin1 papers (2012–2012)Thomas M. Atkinson · Quadram Institute1 papers (2012–2012)Kaled M. Alektiar · Memorial Sloan Kettering Cancer Center1 papers (2012–2012)Anne Eaton · The Ohio State University Wexner Medical Center1 papers (2012–2012)Anuja Jhingran · The University of Texas MD Anderson Cancer Center1 papers (2019–2019)Shari Goldfarb · Memorial Sloan Kettering Cancer Center1 papers (2012–2012)— · 1 papers (2019–2019)Antonia V. Bennett · University of North Carolina at Chapel Hill1 papers (2012–2012)Mario M. Leitão · Memorial Sloan Kettering Cancer Center1 papers (2012–2012)